메뉴 건너뛰기




Volumn 12, Issue 4, 2009, Pages 309-316

Examining and interpreting responsiveness of the Diabetes Medication Satisfaction measure

Author keywords

Asp(B28); Blood glucose drug effects; Diabetes mellitus type 2; Insulin; Patient satisfaction statistics; Psychometrics instrumentation; Questionnaires; Treatment outcomes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; ORAL ANTIDIABETIC AGENT;

EID: 72749120050     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/13696990903337017     Document Type: Article
Times cited : (11)

References (15)
  • 1
    • 33645100092 scopus 로고    scopus 로고
    • Self-reported compliance with insulin injection therapy in subjects with type 1 and 2 diabetes
    • Anderson RT, Marrero D, Skovlund SE, et al. Self-reported compliance with insulin injection therapy in subjects with type 1 and 2 diabetes. Diabetologia 2003;46:A275.
    • (2003) Diabetologia , vol.46
    • Anderson, R.T.1    Marrero, D.2    Skovlund, S.E.3
  • 3
    • 0033653913 scopus 로고    scopus 로고
    • Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes
    • Cappelleri JC, Gerber RA, Kourides IA, et al. Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes Care 2000;23:1799-1803.
    • (2000) Diabetes Care , vol.23 , pp. 1799-1803
    • Cappelleri, J.C.1    Gerber, R.A.2    Kourides, I.A.3
  • 4
    • 11844280839 scopus 로고    scopus 로고
    • Validity and reliability of an instrument for assessing health-related quality of life and treatment preference
    • Peyrot M, Rubin RR. Validity and reliability of an instrument for assessing health-related quality of life and treatment preference. Diabetes Care 2005;28:53-58.
    • (2005) Diabetes Care , vol.28 , pp. 53-58
    • Peyrot, M.1    Rubin, R.R.2
  • 5
    • 1642330561 scopus 로고    scopus 로고
    • Cross-sectional 7-year follow-up of anxiety in primary care patients
    • Colman SS, Brod M, Potter LP, et al. Cross-sectional 7-year follow-up of anxiety in primary care patients. Depress Anxiety 2004;19:105-111.
    • (2004) Depress Anxiety , vol.19 , pp. 105-111
    • Colman, S.S.1    Brod, M.2    Potter, L.P.3
  • 6
    • 0000078123 scopus 로고    scopus 로고
    • Recommendations for evaluating the validity of quality of life claims for labeling and promotion
    • Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999;2:113-127.
    • (1999) Value Health , vol.2 , pp. 113-127
    • Leidy, N.K.1    Revicki, D.A.2    Geneste, B.3
  • 7
    • 0034464640 scopus 로고    scopus 로고
    • Recommendations on health-related quality of life research to support labeling and promotional claims in the United States
    • Revicki DA, Osoba D, Fairclough D, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000;9:887-900.
    • (2000) Qual Life Res , vol.9 , pp. 887-900
    • Revicki, D.A.1    Osoba, D.2    Fairclough, D.3
  • 8
    • 35248883340 scopus 로고    scopus 로고
    • Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL)
    • Matza LS, Johnston JA, Faries DE, et al. Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL). Qual Life Res 2007;16:1511-1520.
    • (2007) Qual Life Res , vol.16 , pp. 1511-1520
    • Matza, L.S.1    Johnston, J.A.2    Faries, D.E.3
  • 9
    • 54049148994 scopus 로고    scopus 로고
    • The IMPROVETM study - A multinational, observational study in type 2 diabetes: Baseline characteristics from eight national cohorts
    • IMPROVE Study Group Expert Panel
    • Valensi P, Benroubi M, Borzi V, et al.; IMPROVE Study Group Expert Panel. The IMPROVETM study - a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts. Int J Clin Pract 2008;62:1809-1819.
    • (2008) Int J Clin Pract , vol.62 , pp. 1809-1819
    • Valensi, P.1    Benroubi, M.2    Borzi, V.3
  • 10
    • 33645097582 scopus 로고    scopus 로고
    • Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience
    • Brod M, Skovlund SE, Wittrup-Jensen K. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res 2006;15:481-491.
    • (2006) Qual Life Res , vol.15 , pp. 481-491
    • Brod, M.1    Skovlund, S.E.2    Wittrup-Jensen, K.3
  • 11
    • 33847634381 scopus 로고    scopus 로고
    • Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: Lessons learned from a clinical trial comparing biphasic and basal analogues
    • Brod M, Cobden D, Lammert M, et al. Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues. Health Qual Life Outcomes 2007;5:8.
    • (2007) Health Qual Life Outcomes , vol.5 , pp. 8
    • Brod, M.1    Cobden, D.2    Lammert, M.3
  • 12
    • 34547436768 scopus 로고    scopus 로고
    • Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes
    • Brod M, Christensen T, Bushnell D. Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes. Qual Life Res 2007;16:1053-1063.
    • (2007) Qual Life Res , vol.16 , pp. 1053-1063
    • Brod, M.1    Christensen, T.2    Bushnell, D.3
  • 13
    • 59349100314 scopus 로고    scopus 로고
    • Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: Safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study
    • IMPROVE Study Group Expert Panel
    • Valensi P, Benroubi M, Borzi V, et al.; IMPROVE Study Group Expert Panel. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study. Int J Clin Pract 2009;63:522-531.
    • (2009) Int J Clin Pract , vol.63 , pp. 522-531
    • Valensi, P.1    Benroubi, M.2    Borzi, V.3
  • 15
    • 0025454512 scopus 로고
    • Comparisons of five health status instruments for orthopedic evaluation
    • Liang MH, Fossel AH, Larson MG: Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990;28:632-642.
    • (1990) Med Care , vol.28 , pp. 632-642
    • Liang, M.H.1    Fossel, A.H.2    Larson, M.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.